NeoStem, Inc. Appoints Stephen W. Potter as Executive Vice President
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK, July 22, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, announced today the appointment of Stephen W. Potter as Executive Vice President of the Company. Mr. Potter is a seasoned and successful senior executive with extensive management experience in the biotechnology and pharmaceutical industries. Stephen has served since February on NeoStem's Board of Directors and its Nominating and Governance Committee. Upon his appointment as Executive Vice President, Stephen resigned from the Company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
NEW YORK, July 22, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, announced today the appointment of Stephen W. Potter as Executive Vice President of the Company. Mr. Potter is a seasoned and successful senior executive with extensive management experience in the biotechnology and pharmaceutical industries. Stephen has served since February on NeoStem's Board of Directors and its Nominating and Governance Committee. Upon his appointment as Executive Vice President, Stephen resigned from the Company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.